167 related articles for article (PubMed ID: 37568555)
1. The Risk and Predictors of Malignancies in Ankylosing Spondylitis Patients in Israel-A Retrospective Electronic Data-Based Study.
Kagan P; Horesh N; Amital H; Tsur AM; Watad A; Cohen AD; Ben-Shabat N
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568555
[TBL] [Abstract][Full Text] [Related]
2. Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5,900 Patients From Israel.
Ben-Shabat N; Shabat A; Watad A; Kridin K; Bragazzi NL; McGonagle D; Comaneshter D; Cohen AD; Amital H
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1614-1622. PubMed ID: 33973404
[TBL] [Abstract][Full Text] [Related]
3. The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study.
Dar L; Ben-Shabat N; Tiosano S; Watad A; McGonagle D; Komaneshter D; Cohen A; Bragazzi NL; Amital H
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300046
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
[TBL] [Abstract][Full Text] [Related]
5. The association between
Wei JC; Chou MC; Huang JY; Chang R; Hung YM
Curr Med Res Opin; 2020 Dec; 36(12):2063-2069. PubMed ID: 33066709
[TBL] [Abstract][Full Text] [Related]
6. Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients.
Chen HH; Chen DY; Lin CC; Chen YM; Lai KL; Lin CH
Ther Clin Risk Manag; 2017; 13():583-592. PubMed ID: 28496328
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study.
Tsai CJ; Lin YC; Chen CY; Hung CH; Lin YC
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760951
[TBL] [Abstract][Full Text] [Related]
9. The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
Cho SK; Lee J; Han M; Bae SC; Sung YK
Arthritis Res Ther; 2017 Dec; 19(1):277. PubMed ID: 29246243
[TBL] [Abstract][Full Text] [Related]
10. Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty.
Stovall R; Peloquin C; Felson D; Neogi T; Dubreuil M
J Rheumatol; 2021 Jul; 48(7):1007-1013. PubMed ID: 33452168
[TBL] [Abstract][Full Text] [Related]
11. Ankylosing spondylitis and the risk of cancer.
Chang CC; Chang CW; Nguyen PA; Chang TH; Shih YL; Chang WY; Horng JT; Lee OK; Ho JH
Oncol Lett; 2017 Aug; 14(2):1315-1322. PubMed ID: 28789346
[TBL] [Abstract][Full Text] [Related]
12. The risk of osteoporosis in patients with ankylosing spondylitis-A large retrospective matched cohort study.
Sharif K; Tsur AM; Ben-Shabat N; Watad A; Cohen AD; Amital H
Med Clin (Barc); 2023 May; 160(9):373-378. PubMed ID: 36697286
[TBL] [Abstract][Full Text] [Related]
13. Low Vitamin D Levels Predict Mortality in Ankylosing Spondylitis Patients: A Nationwide Population-Based Cohort Study.
Ben-Shabat N; Watad A; Shabat A; Bragazzi NL; Comaneshter D; Cohen AD; Amital H
Nutrients; 2020 May; 12(5):. PubMed ID: 32414130
[TBL] [Abstract][Full Text] [Related]
14. The Comparative Safety of TNF Inhibitors in Ankylosing Spondylitis-a Meta-Analysis Update of 14 Randomized Controlled Trials.
Hou LQ; Jiang GX; Chen YF; Yang XM; Meng L; Xue M; Liu XG; Chen XC; Li X
Clin Rev Allergy Immunol; 2018 Apr; 54(2):234-243. PubMed ID: 28717941
[TBL] [Abstract][Full Text] [Related]
15. Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study.
Tsur AM; David P; Watad A; Nissan D; Cohen AD; Amital H
J Gen Intern Med; 2022 Oct; 37(13):3283-3288. PubMed ID: 35411534
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
[TBL] [Abstract][Full Text] [Related]
17. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
18. Association between myelofibrosis and risk of non-hematologic malignancies: a population-based retrospective cohort study.
Saliba W; Khudyakova M; Mishchenko E; Cohen S; Rennert G; Preis M
Ann Hematol; 2020 May; 99(5):1007-1016. PubMed ID: 32157418
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set.
Walsh JA; Song X; Kim G; Park Y
Clin Rheumatol; 2018 Jul; 37(7):1869-1878. PubMed ID: 29637483
[TBL] [Abstract][Full Text] [Related]
20. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
